-
Merck To Showcase Advances In The Science Of Cancer With New Data Presented At ASCO 2024
28 May 2024 03:16 GMT
… metastatic non-small cell lung cancer (NSCLC) harboring METex14 … Avelumab + axitinib vs sunitinib in patients with advanced renal … ) skipping non-small cell lung cancer with brain, liver, adrenal … N 8575 Session Title: Lung Cancer-Non-Small Cell Metastatic
…
-
EMD Serono to Showcase Advances in the Science of Cancer With New Data Presented at ASCO 2024
23 May 2024 21:27 GMT
… metastatic non-small cell lung cancer (NSCLC) harboring METex14 … with axitinib (vs sunitinib) were blood triglycerides increased … advanced non-small cell lung cancer (NSCLC) harboring MET … metastatic non-small cell lung cancer (NSCLC) harboring mesenchymal …
-
Bristol Myers Squibb to Present Data at ASCO & EHA from More Than 130 Studies Across 25 Diseases Supporting Expansion into New Indications, Demonstrating Long-Term Survival, and Highlighting Novel Modalities and Research Platforms
23 May 2024 21:27 GMT
… Poster
Abstract #8522
Lung cancer—Non-Small Cell Metastatic
… plus cabozantinib versus sunitinib in advanced renal … positive) non-small cell lung cancer (NSCLC).
OPDIVO® (nivolumab … cell lung cancer; Checkmate 816-neoadjuvant non-small cell lung cancer, …
-
Eight-Year Data for Opdivo (nivolumab) Plus Yervoy (ipilimumab) Continue to Demonstrate Longest Survival Benefit vs. Sunitinib Reported in Patients with Previously Untreated Advanced or Metastatic Renal Cell Carcinoma
22 Jan 2024 22:20 GMT
… seeing sustained benefits over sunitinib in the primary … node positive) non-small cell lung cancer (NSCLC).
OPDIVO® (nivolumab … metastatic non-small cell lung cancer, in combination with … cell lung cancer; Checkmate 816–neoadjuvant non–small cell lung cancer, …
-
Identification of PDZD11 as a Potential Biomarker Associated with Immune Infiltration for Diagnosis and Prognosis in Epithelial Ovarian Cancer
14 May 2024 08:51 GMT
… the treatment of melanoma,24 lung cancer,25 renal cell carcinoma26 and … /PD-L1 immunotherapy for lung cancer. Int Immunopharmacol. 2020;79:106088 … al. Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma …
-
The Efficacy and Safety of Anlotinib in Extensive-Stage Small Cell Lung Cancer: A Multicenter Real-World Study
02 Aug 2022 00:04 GMT
… to 15% of all lung cancers.1 SCLC comprises … chemotherapy for small cell lung cancer. Lung Cancer. 2006;52(3 … sunitinib in patients with relapsed or refractory small cell lung cancer. Lung Cancer … with relapsed small cell lung cancer. Lung Cancer. 2016;96:108– …
-
LENVIMA Plus KEYTRUDA Demonstrates Long-Term, Durable Survival Benefit Versus Sunitinib
26 May 2023 11:04 GMT
… meaningful OS benefit
versus sunitinib, reducing the risk of … the
superior results versus sunitinib from the primary OS … and ORR
compared to sunitinib. These findings reinforce the … hepatocellular carcinoma, non-small cell lung cancer, RCC,
head and neck …
-
KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) Demonstrates Long-Term, Durable Survival Benefit Versus Sunitinib as First-Line Treatment for Patients With Advanced Renal Cell Carcinoma
25 May 2023 21:35 GMT
… carcinoma, non-small cell lung cancer, RCC, head and neck … KEYTRUDA plus LENVIMA versus sunitinib. Interpretation OS in favorable … resection.
Non-Small Cell Lung Cancer
KEYTRUDA, in combination with … nonsquamous non-small cell lung cancer (NSCLC), with no …
-
Ipsen: ASCO 2022: New Cabometyx® Data Show Encouraging Results in Monotherapy and in Combination Across Different Tumor Types Including Metastatic Non-Small Cell Lung Cancer
26 May 2022 21:17 GMT
… demonstrated deeper responses vs sunitinib. Regardless of treatment, … non-small cell lung cancer (NSCLC)
Lung cancer is one of … of lung cancer - NSCLC and SCLC (small cell lung cancer). … Organization: GLOBOCAN 2020 – Lung Cancer: Estimated cancer incidence, …
-
HUTCHMED Receives a US$15 million Milestone from AstraZeneca for Initiating Start-up Activities for a Global Phase III Study of ORPATHYS® in Lung Cancer
07 Mar 2022 06:00 GMT
… savolitinib plus IMFINZI® versus sunitinib monotherapy versus IMFINZI® … caregivers/lung-cancer-101/types-of-lung-cancer . Accessed … lung cancer – A systematic review and meta-analysis. Lung Cancer 2018 … non-small-cell lung cancers harbouring MET exon …